8-143429783-ATGGTGGTGG-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_201589.4(MAFA):c.615_623delCCACCACCA(p.His206_His208del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000334 in 1,407,144 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00035 ( 1 hom. )
Consequence
MAFA
NM_201589.4 disruptive_inframe_deletion
NM_201589.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.55
Genes affected
MAFA (HGNC:23145): (MAF bZIP transcription factor A) MAFA is a transcription factor that binds RIPE3b, a conserved enhancer element that regulates pancreatic beta cell-specific expression of the insulin gene (INS; MIM 176730) (Olbrot et al., 2002 [PubMed 12011435]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 8-143429783-ATGGTGGTGG-A is Benign according to our data. Variant chr8-143429783-ATGGTGGTGG-A is described in ClinVar as [Likely_benign]. Clinvar id is 2443167.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 29 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAFA | ENST00000333480.3 | c.615_623delCCACCACCA | p.His206_His208del | disruptive_inframe_deletion | 1/1 | 6 | NM_201589.4 | ENSP00000328364.2 | ||
MAFA | ENST00000528185.1 | n.107_115delCCACCACCA | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 29AN: 146948Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
29
AN:
146948
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000558 AC: 38AN: 68082Hom.: 0 AF XY: 0.000617 AC XY: 23AN XY: 37262
GnomAD3 exomes
AF:
AC:
38
AN:
68082
Hom.:
AF XY:
AC XY:
23
AN XY:
37262
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000350 AC: 441AN: 1260076Hom.: 1 AF XY: 0.000354 AC XY: 219AN XY: 619322
GnomAD4 exome
AF:
AC:
441
AN:
1260076
Hom.:
AF XY:
AC XY:
219
AN XY:
619322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 29AN: 147068Hom.: 0 Cov.: 0 AF XY: 0.000167 AC XY: 12AN XY: 71674
GnomAD4 genome
AF:
AC:
29
AN:
147068
Hom.:
Cov.:
0
AF XY:
AC XY:
12
AN XY:
71674
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 09, 2022 | - - |
MAFA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at